Sanofi axes two more inflammatory-disease drugs

Why it matters: The decisions remove two externally sourced drugs from Sanofi’s immunology pipeline, days after the French pharmaceutical group also abandoned amlitelimab, the eczema antibody obtained through its $1.1 billion acquisition of UK biotech Kymab. The decision was announced as part of Sanofi’s Q2 2026 financial results.

CHMP backs first CETP inhibitor after two decades of failure

Why it matters: A new class of cholesterol drug is finally close to reaching the European market. Obicetrapib will be the first CETP inhibitor to ever gain a regulatory nod and to do so on this side of the Atlantic first.

Sipcam Nichino在巴西展出丙硫菌唑新品杀菌剂,聚焦大田作物病害

世界农化网中文网报道:近日,Sipcam Nichino Brasil借Coopercitrus Expo 2026展会之机,提前披露了其新型内吸性杀菌剂Cortina® Gold(丙硫菌唑+百菌清),该产品瞄准大豆、玉米和棉花等大田作物的主要病害防控。

GSK announces plan to axe UK Stevenage R&D hub, moving to Cambridge

Why it matters: It’s a major strategic move by new CEO Luke Miels, who took over on 1st January from Emma Walmsley. GSK said it will vacate its R&D site at Stevenage, Hertfordshire, with a phased move for employees by 2029. Alongside the move to Cambridge, GSK will upgrade its existing R&D laboratories at Ware in Hertfordshire and move some employees there.

山东胜邦绿野创制杀菌剂辛菌胺获ISO临时通用名

世界农化网中文网报道:2026年7月29日,国际标准化组织(ISO)正式批准山东胜邦绿野化学有限公司旗下杀菌剂有效成分的临时通用名称″triseboctylamine″,中文通用名为辛菌胺。

溴氰虫酰胺与新分子双轮驱动,富美实创新产品组合逆势增长

世界农化网中文网报道:日前,富美实公司(NYSE: FMC)公布2026年第二季度财报。

负资产820万美元,UPL以象征性对价将Bioplanta出售给巴西商人

世界农化网中文网报道:7月29日,UPL Limited旗下巴西子公司UPL do Brasil正式获得全部必要监管批准,将所持Bioplanta Nutricao Vegetal Industria e Comercio S.A.的100%股权转让给巴西商人Marino Jose Franz与Miguel Vaz Ribeiro。交易对价仅为象征性的20美元,预计不迟于7月31日完成交割。

山东京博农化子公司年产2000吨肟菌酯原药项目竣工验收

世界农化网中文网报道:近日,山东京博生物科技有限公司3000吨/年肟菌酯原药及配套中间体项目(一期)通过竣工环境保护验收。

中国农药制剂出口:″量增价跌″是主旋律,出口量连续多年双位数增长

世界农化网中文网报道:中国农药制剂出口,是观察行业冷暖最直观的窗口之一。近日,润丰股份″制剂出海月度观察″栏目首篇发布,系统分析了2026年上半年及2022年至今的演变趋势。

美邦股份上半年营收净利双增,持有农药登记证增至1304个

世界农化网中文网报道:7月30日,陕西美邦药业集团股份有限公司(简称″美邦股份″)公告2026年半年度报告。